Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury

MLA

Xin Xu, et al. “Selective NLRP3 Inflammasome Inhibitor Reduces Neuroinflammation and Improves Long-Term Neurological Outcomes in a Murine Model of Traumatic Brain Injury.” Neurobiology of Disease, vol. 117, no. 15–27, Sept. 2018, pp. 15–27. EBSCOhost, https://doi.org/10.1016/j.nbd.2018.05.016.

APA

Xin Xu, Dongpei Yin, Honglei Ren, Weiwei Gao, Fei Li, Dongdong Sun, Yingang Wu, Shuai Zhou, Li Lyu, Mengchen Yang, Jianhua Xiong, Lulu Han, Rongcai Jiang, & Jianning Zhang. (2018). Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiology of Disease, 117(15–27), 15–27. https://doi.org/10.1016/j.nbd.2018.05.016

Chicago

Xin Xu, Dongpei Yin, Honglei Ren, Weiwei Gao, Fei Li, Dongdong Sun, Yingang Wu, et al. 2018. “Selective NLRP3 Inflammasome Inhibitor Reduces Neuroinflammation and Improves Long-Term Neurological Outcomes in a Murine Model of Traumatic Brain Injury.” Neurobiology of Disease 117 (15–27): 15–27. doi:10.1016/j.nbd.2018.05.016.